| Cancer Information Highlights |
| From the National Cancer Institute |
| Updating you about cancer causes, prevention, screening, treatment, coping, and more |
| |
| New from NCI |
| The Challenges of Cancer Misinformation on Social Media |
 |
|
There is a lot of misinformation about cancer on social media, including stories that describe miraculous results from treatments that are not proven and possibly harmful. Researchers are studying misinformation and how it affects people with cancer. |
| Stories of Cancer Research |
 |
|
The NCI Annual Plan & Budget Proposal for Fiscal Year 2023 shares the stories of two people who benefited from NCI research and four NCI-supported researchers who work to find new ways to treat people living with cancer and improve their quality of life. |
Blood Test May Reveal When Benign Tumors Turn into Cancer
NCI scientists developed a blood test that could one day offer a precise and low-cost approach to detect cancer early in people with a genetic disorder called neurofibromatosis type 1 (NF1). The blood test could also help doctors monitor how well people are responding to treatment for their cancer. |
Fungi in the Gut May Affect Radiation Therapy
New research suggests that fungi in the gut may affect how tumors respond to cancer treatments. In a study with mice, when bacteria were destroyed with antibiotics, fungi filled the void and impaired the immune response after radiation therapy. |
| Improving the Future for All Children with Cancer |
 |
|
There have been great strides in childhood cancer research in the last 50 years, but quicker progress is still needed. Learn more about efforts to speed up progress by sharing data, advancing clinical trials, making treatments less toxic, and improving the quality of life for children with cancer. |
Advances in Kidney Cancer Research
NCI-funded researchers are working to advance our understanding of how to find and treat kidney cancer. Much progress has been made over the last few decades, especially in finding genes that can drive the growth of kidney cancer.
|
| FDA Approvals |
Belzutifan
We’ve added a new drug summary for belzutifan (Welireg). The Food and Drug Administration recently approved this drug to treat certain types of kidney, pancreatic, and brain and spinal cord tumors linked to von Hippel-Lindau disease. |
|
| |
| Also of Interest |
Cognitive Impairment in Adults with Non-Central Nervous System Cancers
Cognitive problems, such as trouble with memory and thinking, can occur during and after cancer treatment. These problems are sometimes called "chemobrain" or "chemofog.” Learn more about the causes of cognitive problems and ways to treat them. |
Coronavirus: What People with Cancer Should Know
Learn how to protect yourself from COVID-19 and find advice on extra vaccine shots for people with weakened immune systems. |
Contact Us for Help
Information specialists at NCI’s Cancer Information Service (CIS), NCI's contact center, are available to help answer your cancer-related questions in English and Spanish. Reach us by phone, chat, or email. |
|
|
|
|
|
